📢 Join Us: Virtual Events on Telehealth and Drug Pricing 📢

View in browser ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Wednesday, September 11, 2024 | The Latest Research, Commentary, and News from Health Affairs

Dear John,

ICYMI, last week's episode of Health Affairs This Week explored the latest hurdle to the FTC's attempt to ban noncompete agreements in employment contracts and what the implications are for the health care industry.

Listen
([link removed] )

2024 Election Issues: Drug Costs

In last night's presidential debate, the U.S. heard perspectives from Vice President Kamala Harris and former President Donald Trump on health-related topics, including drug prices, reproductive health, and the Affordable Care Act.

Health care and health policy continue to be talking points on both sides of the aisle leading into the 2024 presidential election.

As the U.S. approaches election day, Health Affairs will highlight a selection of its resources—including journal and Forefront articles, health policy briefs, and podcasts—on issues discussed during the campaign.

Today's topic is drug costs and pharmaceutical spending.

Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations ([link removed] )

Laura Tollen (September 2024)

Catastrophic Spending On Insulin In The United States, 2017–18 ([link removed] )

Baylee F. Bakkila et al. (July 2022)

When Is The Price Of A Drug Unjust? The Average Lifetime Earnings Standard ([link removed] )

Ezekiel J. Emanuel (April 2019)

From “Price Controls” To Robust Public Conversation: How CMS Can Move Drug Price Negotiation Into The Light ([link removed] )

Daniel A. Ollendorf et al. (April 2024)

The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA ([link removed] )

Melanie D. Whittington et al. (October 2023)

PBMs. What Are They Hiding? w/ Stacie Dusetzina ([link removed] ) (August 2024)

Promoting Competition To Address Pharmaceutical Prices ([link removed] )

Jonathan J. Darrow and Aaron S. Kesselheim (March 2018)

Published Today

Medicare Part B Clinician Payment Programs And The Growing Costs Of Administrative Complexity ([link removed] )

Alexander O. Everhart et al.

part of our Accountable Care For Population Health ([link removed] ) series

DA_Events_ALL_year-round_enewsletter_banner ([link removed] )

The Future of Telehealth and Its Impact on Primary Care ([link removed] )

Join Health Affairs Tuesday, September 24, for a virtual event examining the future of telehealth and its impact on primary care.

Join Us
([link removed] )

Biosimilars and Their Impacts on Costs and Market Choices ([link removed] )

Join Health Affairs Wednesday, September 25, for a virtual event examining the biosimilar market and its potential impacts on pharmaceutical market costs.

This event is for Health Affairs Insiders only.

Become an Insider today ([link removed] ) to stay up-to-date on what health care experts are thinking and talking about.

Join Us
([link removed] )

health-affairs-43-09-order-issue_eNewsletter-banner ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs, 1220 19th St. NW, Suite 800, Washington, DC 20036, United States, 202-408-6801

Manage preferences ([link removed] )